Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening.A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy.
Masakazu Toi, Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
1. Introduction of the whole issue.- 2. Breast cancer epidemiology: incidence, risks and subtype.- 3. Personalized genetic breast cancer risk estimation with polygenic risk scores.- 4. Mathematical model forassessing breast cancer risk.- 5. Cost-effectiveness Analysis of multigene testing.- 6. Hereditary breast cancer: Its biology, subtype and clinical phenotype.- 7. Surgical risk reduction of breast cancer.- 8. Medical risk reduction of breast cancer.- 9. Screening for breast cancer with mammography.- 10. Breast cancer screening: Weighing the benefits and harms.- 11. Breast cancer screening according to individual risk.- 12. MRI: Detection of noninvasive diseases.- 13. Significance of MRI for women having dense breasts .- 14. Ultrasound: screening of breast cancer.- 15. Detection of breast cancer by PET.- 16. Radiowave mammography.- 17. Photoacoustic imaging of breast cancer.
“This text provides a unique angle on exploring the harms of screening for breast cancer with an international perspective that incorporates multimodalities. … The book’s target audience is therefore very diverse and it would act as a great reference to anyone with an interest in the breast cancer field.” (Joleen Kirsty Eden, RAD Magazine, February, 2025)